Lange T - Search Results

1

Chemotherapy for mobilisation of Ph-negative progenitor cells from patients with CML: impact of different mobilisation regimens.

Deininger M, Pönisch W, Krahl R, Leiblein S, Edel E, Lange T, Fiedler F, Freund M, Franke A, Pasold R, von Grünhagen U, Herold M, Dölken G, Hoffmann FA, Uhle R, Schultze W, Steglich J, Schwarzer A, Richter P, Winkelmann C, Kettner E, Dachselt K, Subert R, Schwalbe E, Doepper J, Helbig W, Niederwieser D; East German Study Group Haematology/Oncology (OSHO). Deininger M, et al. Among authors: lange t. Bone Marrow Transplant. 2001 Jun;27(11):1125-32. doi: 10.1038/sj.bmt.1703057. Bone Marrow Transplant. 2001. PMID: 11551022 Clinical Trial.

2

Prognostic value of T-1 cell numbers prior to allogeneic stem cell transplantation in patients with severe graft-versus-host disease.

Banning U, Lange T, Krahl R, Mauz-Körholz C, Krutmann J, Niederwieser D, Körholz D. Banning U, et al. Among authors: lange t. Bone Marrow Transplant. 2005 Apr;35(7):691-7. doi: 10.1038/sj.bmt.1704874. Bone Marrow Transplant. 2005. PMID: 15696178

3

The impact of the age of HLA-identical siblings on mobilization and collection of PBSCs for allogeneic hematopoietic cell transplantation.

Al-Ali HK, Bourgeois M, Krahl R, Edel E, Leiblein S, Poenisch W, Basara N, Lange T, Niederwieser D. Al-Ali HK, et al. Among authors: lange t. Bone Marrow Transplant. 2011 Oct;46(10):1296-302. doi: 10.1038/bmt.2010.310. Epub 2010 Dec 6. Bone Marrow Transplant. 2011. PMID: 21132022

4

High levels of BAX, low levels of MRP-1, and high platelets are independent predictors of response to imatinib in myeloid blast crisis of CML.

Lange T, Günther C, Köhler T, Krahl R, Musiol S, Leiblein S, Al-Ali HK, van Hoomissen I, Niederwieser D, Deininger MW. Lange T, et al. Blood. 2003 Mar 15;101(6):2152-5. doi: 10.1182/blood-2002-05-1366. Epub 2002 Oct 24. Blood. 2003. PMID: 12406906 Free article. Clinical Trial.

5

High incidence of BCR-ABL kinase domain mutations and absence of mutations of the PDGFR and KIT activation loops in CML patients with secondary resistance to imatinib.

Al-Ali HK, Heinrich MC, Lange T, Krahl R, Mueller M, Müller C, Niederwieser D, Druker BJ, Deininger MW. Al-Ali HK, et al. Among authors: lange t. Hematol J. 2004;5(1):55-60. doi: 10.1038/sj.thj.6200319. Hematol J. 2004. PMID: 14745431

6

Quantitative reverse transcription polymerase chain reaction should not replace conventional cytogenetics for monitoring patients with chronic myeloid leukemia during early phase of imatinib therapy.

Lange T, Bumm T, Otto S, Al-Ali HK, Kovacs I, Krug D, Köhler T, Krahl R, Niederwieser D, Deininger MW. Lange T, et al. Haematologica. 2004 Jan;89(1):49-57. Haematologica. 2004. PMID: 14754606

7

Low-dose total body irradiation-based regimens as a preparative regimen for allogeneic haematopoietic cell transplantation in acute myelogenous leukaemia.

Al-Ali H, Cross M, Lange T, Freund M, Dölken G, Niederwieser D. Al-Ali H, et al. Among authors: lange t. Curr Opin Oncol. 2009 Jun;21 Suppl 1:S17-22. doi: 10.1097/01.cco.0000357470.91584.62. Curr Opin Oncol. 2009. PMID: 19561407

8

Clinical impact of clonal hematopoiesis in acute myeloid leukemia patients receiving allogeneic transplantation.

Grimm J, Bill M, Jentzsch M, Beinicke S, Häntschel J, Goldmann K, Schulz J, Cross M, Franke GN, Behre G, Vucinic V, Pönisch W, Lange T, Niederwieser D, Schwind S. Grimm J, et al. Among authors: lange t. Bone Marrow Transplant. 2019 Aug;54(8):1189-1197. doi: 10.1038/s41409-018-0413-0. Epub 2018 Nov 30. Bone Marrow Transplant. 2019. PMID: 30504903

9

Prospective phase II study of preemptive chimerism-driven reduction of immunosuppression after non-myeloablative conditioning-Eudract #: 2007-002420-15.

Hell S, Jentzsch M, Franke GN, Jäkel N, Schulze S, Edelmann J, Nenoff K, Grieb N, Jeremic V, Cross M, Leiblein S, Bach E, Pönisch W, Al-Ali HK, Schwind S, Platzbecker U, Lange T, Niederwieser D, Vucinic V. Hell S, et al. Among authors: lange t. Bone Marrow Transplant. 2022 May;57(5):824-826. doi: 10.1038/s41409-022-01609-6. Epub 2022 Feb 18. Bone Marrow Transplant. 2022. PMID: 35181744 Free PMC article. Clinical Trial. No abstract available.

10

BCR-ABL transcripts are early predictors for hematological relapse in chronic myeloid leukemia after hematopoietic cell transplantation with reduced intensity conditioning.

Lange T, Deininger M, Brand R, Hegenbart U, Al-Ali H, Krahl R, Poenisch W, Uharek L, Leiblein S, Gentilini C, Petersdorf E, Storb RF, Niederwieser D. Lange T, et al. Leukemia. 2004 Sep;18(9):1468-75. doi: 10.1038/sj.leu.2403425. Leukemia. 2004. PMID: 15241437

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,497 results

Search Page

Filters